May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Co-Expression of Prostaglandin FP Receptor and FP Receptor mRNA Splicing Variants Confers Prostamide-Like Pharmacology
Author Affiliations & Notes
  • D. F. Woodward
    Allergan, Inc, Irvine, California
    Biological Sciences RD-2C, Biological Sciences, Membrane Biology,
    Allergan Inc, Irvine, California
  • Y. Liang
    Allergan, Inc, Irvine, California
    Biological Sciences RD-2C, Biological Sciences, Membrane Biology,
    Biological Sciences, Allergan Inc., Irvine, California
  • L. A. Wheeler
    Allergan, Inc, Irvine, California
    Biological Sciences RD-2C, Biological Sciences, Membrane Biology,
    Biological Sciences, Allergan, Irvine, California
  • M. E. Garst
    Allergan, Inc, Irvine, California
    Chemical Sciences, Chemical Sciences, Membrane biology,
    Allergan Inc, Irvine, California
  • D. F. Scott
    Biological Sciences RD-2C, Biological Sciences, Membrane Biology,
    University of California at Los Angeles ( UCLA), Los Angeles, California
  • G. Sachs
    Biological Sciences RD-2C, Biological Sciences, Membrane Biology,
    Chemical Sciences, Chemical Sciences, Membrane biology,
    University of California at Los Angeles ( UCLA), Los Angeles, California
  • C. L. Cornell
    Chemistry, Selcia Ltd., Ongar , Essex, United Kingdom
    Chemistry, Selcia Ltd, Ongar , Essex, United Kingdom
  • J. L. Martos
    Chemistry, Selcia Ltd, Ongar , Essex, United Kingdom
  • S. N. Pettit
    Chemistry, Selcia Ltd, Ongar , Essex, United Kingdom
  • H. G. Fliri
    Chemistry, Selcia Ltd, Ongar , Essex, United Kingdom
  • Footnotes
    Commercial Relationships  D.F. Woodward, Allergan Inc., E; Y. Liang, Allergan INc, E; L.A. Wheeler, Allergan Inc, E; M.E. Garst, Allergan Inc, E; D.F. Scott, None; G. Sachs, Allergan Inc, C; C.L. Cornell, Selcia Ltd, E; J.L. Martos, Selcia Ltd, E; S.N. Pettit, Selcia Ltd, E; H.G. Fliri, Selcia Ltd, E.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2610. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D. F. Woodward, Y. Liang, L. A. Wheeler, M. E. Garst, D. F. Scott, G. Sachs, C. L. Cornell, J. L. Martos, S. N. Pettit, H. G. Fliri; Co-Expression of Prostaglandin FP Receptor and FP Receptor mRNA Splicing Variants Confers Prostamide-Like Pharmacology. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2610. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate prostanoid FP receptor alternative mRNA splicing variants as the putative prostamide receptor

Methods: : RT-PCR analyses were performed on human and monkey ciliary body cDNA libraries using FP receptor specific primers. Novel PCR products were subcloned and sequenced. Stable transfectants of wt. FP receptors, FP receptor mRNA alternative splicing variants (alt.FP) and co-transfections of FP/alt-FP were prepared in HEK 293/EBNA cells using retrovirus vector. Northern blots, MLC phophorylation, and Ca2+ signaling (FLIPR) experiments adhered to standard protocols. Isolated tissue pharmacology was performed using feline iris sphincter smooth muscle. Pneumatonometry was conducted in conscious dogs (BASi, Evansville, USA).

Results: : Six new alternative splicing variants of FP receptor mRNA were found in both human and monkey ciliary bodies. Each lacked the 7th TM spanning segment, the carboxyl termini were extracellular, and they appeared functionally inert. When co-expressed with wt FP receptors, prostamide-like activity was conferred. Bimatoprost exhibited no meaningful activity in FP receptor transfects but in FP/alt FP co-transfects it produced a pronounced Ca2+ transient followed by a second Ca2+ wave. The secondary Ca2+ response was susceptible to the prostamide antagonist AGN 211335 (pA2 = 7.5 in feline iris). Similarly, Cyr 61 upregulation and MLC phosphorylation produced by bimatoprost in FP/alt FP co-transfectants was susceptible to AGN 211335. AGN 211335 did not alter PGF effects. Finally, AGN 211335 blocked the ocular hypotensive response to bimatoprost but not latanoprost.

Conclusions: : These data suggest that the effects of prostamides, as determined by their susceptibility to AGN 211334-6, may be mediated by a wt FP/alt FP interaction. Preliminary evidence suggests that FP/alt FP may form a heterodimeric association.

Keywords: receptors: pharmacology/physiology • eicosanoids • intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×